1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Left Ventricular Hypertrophy: new trials by email Literature Review of Left Ventricular Hypertrophy trials Research Report on Left Ventricular Hypertrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SGLT2 Inhibition in Hemodialysis Dapagliflozin 10 MG, Placebo - Kidney Failure, Hemodialysis | Phase 2 | Completed | Medical University of Vienna | 220 | 2022-10-01 | 2026-03-03 |
Diabetes Mellitus, Type 2 (1) · Hypertrophy, Left Ventricular (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Cardiomegaly (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Diabetes Mellitus (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Hypertrophy (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
dapagliflozin (1)
Medical University of Vienna (1)
Austria (1)
Manfred Hecking, MD, PhD (1) · Thomas A Zelniker, MD, MSc (1)